These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37012339)

  • 61. Proof-of-principle Intellia trial shows in vivo CRISPR activity.
    Mullard A
    Nat Rev Drug Discov; 2022 Apr; 21(4):249. PubMed ID: 35277676
    [No Abstract]   [Full Text] [Related]  

  • 62. Whole-body CRISPR editing.
    Perdigoto CN
    Nat Struct Mol Biol; 2022 Aug; 29(8):729. PubMed ID: 35948771
    [No Abstract]   [Full Text] [Related]  

  • 63. Editorial: CRISPR and alternative approaches.
    Kapusi E; Cong L; Stoger E
    Biotechnol J; 2022 Jul; 17(7):e2200290. PubMed ID: 35726663
    [No Abstract]   [Full Text] [Related]  

  • 64. CRISPR Rewrites the Future of Medicine.
    Barrangou R
    CRISPR J; 2022 Feb; 5(1):1. PubMed ID: 35191754
    [No Abstract]   [Full Text] [Related]  

  • 65. Cardiac defect corrected in vivo with CRISPR.
    Fudge JB
    Nat Biotechnol; 2023 Mar; 41(3):323. PubMed ID: 36922689
    [No Abstract]   [Full Text] [Related]  

  • 66. Assessing Off-Target Editing of CRISPR-Cas9 Systems.
    Pruett-Miller SM
    CRISPR J; 2020 Dec; 3(6):430-432. PubMed ID: 33346715
    [No Abstract]   [Full Text] [Related]  

  • 67. Combination therapy for HCC: from CRISPR screening to the design of clinical therapies.
    Wang Y; Kui L; Wang G
    Signal Transduct Target Ther; 2021 Oct; 6(1):359. PubMed ID: 34608130
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of CRISPR/Cas9 system for targeted DNA modifications and recent improvements in modification efficiency and specificity.
    Shin J; Oh JW
    BMB Rep; 2020 Jul; 53(7):341-348. PubMed ID: 32580834
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
    Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
    J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amplifying CRISPR: Next-Generation Diagnostics.
    Barrangou R
    CRISPR J; 2023 Apr; 6(2):85. PubMed ID: 37071671
    [No Abstract]   [Full Text] [Related]  

  • 71. Navigating Viral Space with CRISPR Technologies.
    Barrangou R
    CRISPR J; 2022 Aug; 5(4):487. PubMed ID: 35972366
    [No Abstract]   [Full Text] [Related]  

  • 72. Broad defeats Berkeley CRISPR patent.
    Shaffer C
    Nat Biotechnol; 2022 Apr; 40(4):445. PubMed ID: 35288688
    [No Abstract]   [Full Text] [Related]  

  • 73. CRISPR Milestones and Anticipating What Is Next for the Journal.
    Barrangou R
    CRISPR J; 2021 Dec; 4(6):771-772. PubMed ID: 34935490
    [No Abstract]   [Full Text] [Related]  

  • 74. CRISPR editing within microbial communities.
    Koch L
    Nat Rev Genet; 2022 Feb; 23(2):72. PubMed ID: 34880423
    [No Abstract]   [Full Text] [Related]  

  • 75. Twelve genes at one blow: multiplex genome editing with CRISPR/Cas.
    Verhage L
    Plant J; 2021 Apr; 106(1):6-7. PubMed ID: 33861513
    [No Abstract]   [Full Text] [Related]  

  • 76. Weakly immunogenic CRISPR therapies.
    Wilson EA; Anderson KS
    Nat Biomed Eng; 2019 Oct; 3(10):761-762. PubMed ID: 31591524
    [No Abstract]   [Full Text] [Related]  

  • 77. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
    Wang W; Hou J; Zheng N; Wang X; Zhang J
    Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
    [No Abstract]   [Full Text] [Related]  

  • 78. CRISPR/dCas-mediated transcriptional and epigenetic regulation in plants.
    Pan C; Sretenovic S; Qi Y
    Curr Opin Plant Biol; 2021 Apr; 60():101980. PubMed ID: 33401227
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

  • 80. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
    Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
    J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.